Investigation of molecular and cellular determinants of Immune Related Adverse Events following treatment with Immune Checkpoint Inhibitors [ 2018 - ]

Research Grant

Researchers: Dr Anthea Anantharajah (Principal investigator)

Brief description Novel immune-based treatments for advanced, incurable, cancer have significantly improved patient survival. Although these treatments have proven highly effective, they are associated with the unpredictable development of severe and sometimes life-threatening autoimmune disease. We aim to discover ways to predict and potentially prevent these complications by identifying genetic risk factors and markers in blood samples. If successful, this will be a ground breaking advance in cancer care.

Funding Amount $126,437.00

Funding Scheme Postgraduate Scholarships

Notes Medical/Dental Postgraduate Scholarship